Upgrade to SI Premium - Free Trial

Medtronic, Inc. (MDT) PT Raised to $149 at UBS After Reiterating Organic Guidance Despite Headwinds

August 25, 2021 7:07 AM
UBS analyst Matthew Taylor raised the price target on Medtronic, Inc. (NYSE: MDT) to $149.00 (from $145.00) after the company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles